Shionogi & Co., Ltd.
塩野義製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4507
FY2025 · 2026-03-31
| Gross margin | 83.5% |
| Operating margin | 33.4% |
| Net margin | 41.1% |
| Return on equity | 12.2% |
| Return on assets | 8.0% |
| Revenue growth (YoY) | 14.0% |
| EPS (basic) | ¥241.11 |
| EPS growth (YoY) | 20.3% |
| Current ratio | — |
| Equity ratio | 65.4% |
| Book value / share | ¥1,023.68 |
| Free cash flow | 199,108 M |